Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emanuelli, B.
Right arrow Articles by Van Obberghen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emanuelli, B.
Right arrow Articles by Van Obberghen, E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:S97-S103, 2004
© 2004 by the American Diabetes Association, Inc.


Section II: Beta-Cell Therapeutic Targets Other Than ATP-Sensitive K+ Channels

The Potential Role of SOCS-3 in the Interleukin-1ß-Induced Desensitization of Insulin Signaling in Pancreatic Beta-Cells

Brice Emanuelli, Murielle Glondu, Chantal Filloux, Pascal Peraldi, and Emmanuel Van Obberghen

From INSERM U145, Faculty of Medicine, Nice, France

Defects in insulin secretion, resulting from loss of function or destruction of pancreatic ß-cells, trigger diabetes. Interleukin (IL)-1ß is a proinflammatory cytokine that is involved in type 1 and type 2 diabetes development and impairs ß-cell survival and function. Because effective insulin signaling is required for the optimal ß-cell function, we assessed the effect of IL-1ß on the insulin pathway in a rat pancreatic ß-cell line. We show that IL-1ß decreases insulin-induced tyrosine phosphorylation of the insulin receptor (IR) and insulin receptor substrate (IRS) proteins as well as phosphatidylinositol 3-kinase (PI3K) activation, and that this action is not due to the IL-1ß-dependent nitric oxide (NO) production in RINm5F cells. We next analyzed if suppressor of cytokine signaling (SOCS)-3, which can be induced by multiple cytokines and which we identified as an insulin action inhibitor, was implicated in the IL-1ß inhibitory effect on insulin signaling in these cells. We show that IL-1ß increases SOCS-3 expression and induces SOCS-3/IR complex formation in RINm5F cells. Moreover, we find that ectopically expressed SOCS-3 associates with the IR and reduces insulin-dependent IR autophosphorylation and IRS/PI3K pathway in a way comparable to IL-1ß treatment in RINm5F cells. We propose that IL-1ß decreases insulin action in ß-cells through the induction of SOCS-3 expression, and that this effect potentially alters insulin-induced ß-cell survival.


Address correspondence and reprint requests to Emmanuel Van Obberghen, INSERM U145, IFR-50, Faculty of Medicine, 06107 Nice Cedex 2. France. E-mail: vanobbeg{at}unice.fr


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
X. Liu, M. G. Mameza, Y. S. Lee, C. I. Eseonu, C.-R. Yu, J. J. Kang Derwent, and C. E. Egwuagu
Suppressors of Cytokine-Signaling Proteins Induce Insulin Resistance in the Retina and Promote Survival of Retinal Cells
Diabetes, June 1, 2008; 57(6): 1651 - 1658.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. A. Gysemans, L. Ladriere, H. Callewaert, J. Rasschaert, D. Flamez, D. E. Levy, P. Matthys, D. L. Eizirik, and C. Mathieu
Disruption of the {gamma}-Interferon Signaling Pathway at the Level of Signal Transducer and Activator of Transcription-1 Prevents Immune Destruction of {beta}-cells
Diabetes, August 1, 2005; 54(8): 2396 - 2403.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.